At a live Case-Based Roundtable event during the 2025 American Society of Hematology (ASH) annual meeting, Joshua Richter, MD, discussed the evolving role of selinexor (Xpovio) in ...
The FDA accepted the new drug application for iberdomide based on minimal residual disease negativity benefit shown in the ...
Enrollment for Phase 2 MOMENTUM Trial Expected to Be Completed in Q1 2027 Phase 1b Trial of Cemsidomide in Combination with Elranatamab on Track ...
Cemsidomide Advancing into Later-stage Development with Potential for Accelerated Approval; First Patient Dosed in the Phase 2 MOMENTUM Trial for ...
A horse who won handicaps almost a year apart for different trainers has been disqualified from both races after testing ...
A red, parasitic worm turned out to be behind the woman's wide array of symptoms. | Credit: Hossain, M., Kennedy, K. J., ...
The U.S. Food and Drug Administration (FDA) recently approved the use of Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with Velcade (bortezomib), Revlimid (l ...
Patients with cancer who meditate each morning and evening could reduce the chance of it spreading, scientists say.
COVID-19 severity appears to be declining among hospitalized children as the Omicron variant continues to evolve.
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best value stocks to buy now. On February 17, Bristol Myers Squibb ...
The U.S. Food and Drug Administration (FDA) has accepted a new drug application for iberdomide combined with Darzalex ...
A dad-of-three has been in hospital for more than three weeks after a severe reaction to treatment used after a routine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results